Trial Profile
Phase I clinical trial of PENNVAX-GP (HIV clades A C B DNA vaccine) as an immune therapy in patients with HIV infections.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2015
Price :
$35
*
At a glance
- Drugs HIV clades A C B DNA vaccine Inovio (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Inovio Pharmaceuticals
- 27 Jan 2015 New trial record